HomeSPRY • NASDAQ
add
ARS Pharmaceuticals Inc
Previous close
$17.26
Day range
$17.27 - $18.21
Year range
$7.89 - $18.51
Market cap
1.78B USD
Avg Volume
1.42M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 7.97M | — |
Operating expense | 41.10M | 416.51% |
Net income | -33.94M | -229.77% |
Net profit margin | -425.69 | — |
Earnings per share | -0.35 | -218.18% |
EBITDA | -36.90M | -179.93% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 275.73M | 23.29% |
Total assets | 327.32M | 43.82% |
Total liabilities | 98.34M | 2,547.21% |
Total equity | 228.97M | — |
Shares outstanding | 98.21M | — |
Price to book | 7.41 | — |
Return on assets | -27.40% | — |
Return on capital | -29.76% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -33.94M | -229.77% |
Cash from operations | -40.74M | -507.18% |
Cash from investing | 29.06M | 441.41% |
Cash from financing | 725.00K | 181.01% |
Net change in cash | -10.95M | 26.81% |
Free cash flow | -21.46M | -639.66% |
About
Founded
2015
Website
Employees
158
